Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
H&R GmbH KGaAXTER:2HRA +0.89%64 EV-to-EBITDA is 4.30 as of Sep. 01, 2026, which is 11% below its 10-year median of 4.83. GuruFocus rates XTER:2HRA with a GF Score™ of 64/100 and a GF Value™ of €4.73 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,341 Chemicals companies, H&R GmbH KGaA ranks better than 89.26% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, H&R GmbH KGaA's enterprise value is €380 Mil.
H&R GmbH KGaA's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was €88 Mil. Therefore, H&R GmbH KGaA's EV-to-EBITDA for today is 4.30.
The historical rank and industry rank for H&R GmbH KGaA's EV-to-EBITDA or its related term are showing as below:
XTER:2HRA'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.44 Med: 4.83 Max: 10.93
Current: 4.31
During the past 13 years, the highest EV-to-EBITDA of H&R GmbH KGaA was 10.93. The lowest was 2.44. And the median was 4.83.
XTER:2HRA's EV-to-EBITDA is ranked better than 89.26% of 1341
companies
in the Chemicals industry
Industry Median: 12.38
vs XTER:2HRA: 4.31
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
H&R GmbH KGaA's PE Ratio (TTM) for today is calculated as:
H&R GmbH KGaA's share price for today is €6.80.
H&R GmbH KGaA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.060.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for H&R GmbH KGaA's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:2HRA vs LIN, SHW, ECL: EV-to-EBITDA Comparison
For the Specialty Chemicals subindustry, H&R GmbH KGaA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H&R GmbH KGaA EV-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, H&R GmbH KGaA's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where H&R GmbH KGaA's EV-to-EBITDA falls into.
H&R GmbH KGaA's current Enterprise Value is €380 Mil.
H&R GmbH KGaA's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €88 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H&R GmbH KGaA (XTER:2HRA) has a EV-to-EBITDA of 4.30 as of Sep. 01, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on H&R GmbH KGaA. This is 11% below median its historical median of 4.83. Over the past decade, H&R GmbH KGaA's EV-to-EBITDA has ranged from 2.44 to 10.93. According to the industry distribution chart, H&R GmbH KGaA ranks #144 out of 1341 companies in the Chemicals industry, placing it in the top 10.7%.
Is H&R GmbH KGaA's EV-to-EBITDA too high?
H&R GmbH KGaA's current EV-to-EBITDA of 4.30 is 11% below median its 10-year median of 4.83. Over the past 10 years, this metric has ranged from a low of 2.44 to a high of 10.93. The Chemicals industry median EV-to-EBITDA is 12.38. H&R GmbH KGaA's value of 4.30 is 65.3% below this industry median. Based on the distribution chart, H&R GmbH KGaA ranks #144 out of 1341 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, H&R GmbH KGaA has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H&R GmbH KGaA's EV-to-EBITDA compare to LIN and SHW?
According to the Chemicals industry distribution chart, H&R GmbH KGaA ranks #144 out of 1341 companies for EV-to-EBITDA. This places H&R GmbH KGaA in the top 11% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 12.38. H&R GmbH KGaA's value of 4.30 is 65.3% below this benchmark. Historically, H&R GmbH KGaA's own EV-to-EBITDA has ranged from 2.44 to 10.93 over the past decade. While the company's 10-year median is 4.83 vs. the industry median of 12.38, H&R GmbH KGaA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Chemicals company?
The median EV-to-EBITDA among Chemicals companies is 12.38, based on 1,341 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. H&R GmbH KGaA's current EV-to-EBITDA of 4.30 is 65.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on H&R GmbH KGaA. For the Chemicals industry, the median EV-to-EBITDA is 12.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H&R GmbH KGaA's current EV-to-EBITDA is 4.30, which is 11% below median its own 10-year median of 4.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H&R GmbH KGaA stock overvalued right now?
Based on GuruFocus' analysis, H&R GmbH KGaA (XTER:2HRA) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.73, compared to a current price of €6.80 — trading 43.8% above its estimated fair value. The current EV-to-EBITDA is 4.30, which is 11% below median its 10-year median of 4.83 and 65.3% below the Chemicals industry median of 12.38. H&R GmbH KGaA's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For H&R GmbH KGaA (XTER:2HRA), the current EV-to-EBITDA is 4.30 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H&R GmbH KGaA (XTER:2HRA) Overvalued in 2026?
Based on GuruFocus' analysis, H&R GmbH KGaA stock appears to be overvalued.
The current stock price of €6.80 is trading 43.8% above its estimated GF Value™ of €4.73.
GuruFocus considers H&R GmbH KGaA to be Significantly Overvalued.
Key valuation signals for XTER:2HRA:
EV-to-EBITDA: 4.30 (11% below median its 10-year median of 4.83)
GF Value™: €4.73 vs. price of €6.80 (43.8% above fair value)
Industry Position: 65.3% below the Chemicals median (#144 of 1341)
No single metric tells the full story. See the XTER:2HRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
64GF Score
Get the complete analysis for XTER:2HRA
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:2HRA has been successfully added to your 
